CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 37 enrolled
Drug / intervention
CARES Interventionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03698708
NCT03698708N/ACompleted
CompareCT.gov

Longitudinal Test of Adherence & Control in Kids New to Type 1 Diabetes & 5-9 Years Old

University of Kansas Medical Center·interventional·Posted Oct 9, 2018·Updated Feb 11, 2022

In Brief

A clinical study evaluating CARES Intervention for Type 1 Diabetes Mellitus. Completed, enrolled 37 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate a new intervention (CARES: Cognitive Adaptations to Reduce Emotional Stress Associated with Type 1 Diabetes) designed to reduce caregiver depressive symptoms in families of children with T1D. This is a pilot in which all enrolled parents/caregivers will be placed in the intervention group to assess initial pre- to post-treatment impact of the intervention on parent/caregiver depression, distress, and diabetes-related outcomes (e.g., glycemic control).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes Mellitus
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedOct 9, 2018
Enrollment StartJan 20, 2019
Primary CompletionJul 31, 2020
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 7.7 years ago

Interventions

CARES Interventionbehavioral

A group-based telemedicine intervention to treat depression in parents/caregivers of children with T1D using a cognitive-behavioral approach.